axitinib

Axitinib is an indazole derivative. It is most commonly marketed under the name Inlyta® and is available in oral formulations._x000D_ Axitinib is a second generation tyrosine kinase inhibitor that works by selectively inhibiting vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, VEGFR-3).7. Reference standards of Axitinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Axitinib-d3
    [catalogue_number] => PA STI 009300
    [category_ids] => ,80,81,78,70,82,117,98,
    [chemical_name] => 
    [weight] => 389.49
    [form] => C22H15D3N4OS
    [cas] => 1126623-89-9
    [pslug] => 1126623-89-9-axitinib-d3-pasti009300
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)

Axitinib-d3

Catalogue No.:PA STI 009300
CAS :
1126623-89-9
Molecular Formula : C₂₂H₁₅D₃N₄OS
Molecular Weight : 389.49

Enquire

Details

stdClass Object
(
    [pname] => Axitinib-13C-d3
    [catalogue_number] => PA STI 009301
    [category_ids] => ,98,
    [chemical_name] => 
    [weight] => 390.48
    [form] => C2113CH15D3N4OS
    [cas] => 1261432-00-1
    [pslug] => 1261432-00-1-axitinib-13c-d3-pasti009301
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)